Concurrent Investment Advisors LLC Purchases 27,135 Shares of Counterpoint Quantitative Equity ETF $CPAI

Concurrent Investment Advisors LLC boosted its position in Counterpoint Quantitative Equity ETF (NYSEARCA:CPAI) by 59.4% in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 72,844 shares of the company’s stock after purchasing an additional 27,135 shares during the period. Concurrent Investment Advisors LLC owned 2.40% of Counterpoint Quantitative Equity ETF worth $2,877,000 at the end of the most recent quarter.

A number of other hedge funds have also recently made changes to their positions in the company. JPMorgan Chase & Co. grew its position in shares of Counterpoint Quantitative Equity ETF by 4.9% in the 2nd quarter. JPMorgan Chase & Co. now owns 6,130 shares of the company’s stock valued at $228,000 after buying an additional 286 shares during the last quarter. Raymond James Financial Inc. bought a new stake in Counterpoint Quantitative Equity ETF in the second quarter valued at approximately $1,121,000. Avantax Advisory Services Inc. increased its position in Counterpoint Quantitative Equity ETF by 27.7% during the 2nd quarter. Avantax Advisory Services Inc. now owns 56,600 shares of the company’s stock valued at $2,105,000 after purchasing an additional 12,266 shares during the period. U.S. Capital Wealth Advisors LLC increased its position in Counterpoint Quantitative Equity ETF by 168.7% during the 2nd quarter. U.S. Capital Wealth Advisors LLC now owns 62,660 shares of the company’s stock valued at $2,330,000 after purchasing an additional 39,339 shares during the period. Finally, Steward Partners Investment Advisory LLC raised its holdings in Counterpoint Quantitative Equity ETF by 102.9% during the 2nd quarter. Steward Partners Investment Advisory LLC now owns 68,061 shares of the company’s stock worth $2,531,000 after purchasing an additional 34,518 shares during the last quarter.

Counterpoint Quantitative Equity ETF Stock Performance

NYSEARCA:CPAI opened at $44.18 on Friday. Counterpoint Quantitative Equity ETF has a 52 week low of $28.48 and a 52 week high of $44.67. The firm’s fifty day moving average is $40.46 and its 200-day moving average is $38.61. The firm has a market cap of $161.70 million, a P/E ratio of -52,973.62 and a beta of 1.25.

Counterpoint Quantitative Equity ETF Dividend Announcement

The firm also recently announced an annual dividend, which was paid on Wednesday, December 17th. Investors of record on Friday, December 12th were given a dividend of $0.3577 per share. The ex-dividend date was Friday, December 12th. This represents a dividend yield of 89.0%. Counterpoint Quantitative Equity ETF’s dividend payout ratio is presently -16,786.57%.

Counterpoint Quantitative Equity ETF Company Profile

The Counterpoint Quantitative Equity ETF (CPAI) is an exchange-traded fund that mostly invests in total market equity. The fund is actively managed, seeking long-term capital appreciation through a quantitative, model-based approach to select US stocks of any market capitalization. CPAI was launched on Nov 28, 2023 and is issued by Counterpoint.